Cancer drug 'could hold the key to rejuvenated fertility'

A drug used to treat cancer could reportedly hold the key to rejuvenated fertility in women, after it was apparently found to 'revive' ovaries. 

Scientists at the University of Edinburgh, Scotland, were looking at the effects of chemotherapy on ovarian tissue in a group of women aged between 16 and 29, who had been treated for Hodgkin's lymphoma with the drug ABVD. 

They had expected to see damage to the tissue as a result of the treatment, so were shocked to discover that in reality,  the samples contained surprising numbers of non-growing follicles containing immature eggs that seemed to be newly formed, suggesting revival of ovarian tissues. 

Groups of both healthy women in the same age group, and those who had been treated with different drugs, both showed far lower levels. 

Lead scientist Professor Evelyn Telfer, from the University of Edinburgh, said: "This was an astonishing result that we didn't expect. It's not what we set out even to look at.

"The tissue looked more like that of pre-pubescent than adult ovaries. It wasn't just the fact that there were more immature eggs, it was the way they were organised and clustered. There were features that we only see in the young ovary."ADNFCR-2094-ID-801830520-ADNFCR